B.13 December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * * | * * * * | * * * * | * * | * | | 5- 9 | * 0 0 0 | * * * 0 | * * * 0 | * * | * | | 10-14 | * 0 0 0 | * * 0 0 | * * 0 0 | * * | * | | 15-19 | * 19 * 0 | * 23 * 0 | * 21 * 0 | * * | * | | 20-24 | 67 196 * * | 87 350 * 274 | 77 275 * 190 | 81 120 | 101 | | 25-29 | 526 972 153 261 | 581 1287 154 900 | 554 1134 154 588 | 566 657 | 613 | | 30-34 | 1610 2048 548 1625 | 1348 1917 522 2254 | 1477 1982 536 1949 | 1627 1399 | 1511 | | 35-39 | 2438 3035 1125 3694 | 1719 2688 879 3685 | 2070 2852 997 3686 | 2475 1826 | 2144 | | 40-44 | 3077 5972 1820 8561 | 2055 4346 994 6006 | 2550 5123 1391 7217 | 3436 2334 | 2872 | | 45-49 | 3762 11818 3254 19997 | 2455 9590 2232 14545 | 3080 10614 2709 17077 | 4877 3428 | 4135 | | 50-54 | 4574 20305 6894 31954 | 3134 19431 3718 28175 | 3824 19794 5237 29925 | 6851 5407 | 6114 | | 55-59 | 5603 30806 9845 46576 | 4573 31289 7652 48165 | 5064 30954 8648 47184 | 9255 8405 | 8823 | | 60-64 | 6723 36645 14733 54834 | 6259 42926 10686 69137 | 6495 39826 12588 62035 | 11200 11585 | 11407 | | 65-69 | 7473 34427 18384 54670 | 7377 50413 16749 80166 | 7431 42521 17476 67519 | 11660 13767 | 12764 | | 70-74 | 7109 33352 19781 34411 | 6925 50418 20891 72280 | 7013 42018 20230 53529 | 11095 13465 | 12335 | | 75-79 | 5523 25081 18237 26339 | 4688 35816 19730 46565 | 5073 30429 18720 36394 | 8576 9473 | 9055 | | 80-84 | 3597 16736 14392 17643 | 2674 21080 14774 26049 | 3106 18930 14331 21898 | 5726 5615 | 5679 | | 85 plus | 1517 6941 8490 * | 839 6539 6629 7270 | 1162 6676 7305 4797 | 2435 1801 | 2111 | | All Age | 2339 6280 2647 8106 | 2070 8516 2534 10560 | 2202 7455 2589 9342 | 2881 2993 | 2938 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2346 8944 4004 12389 | 1910 10388 3433 15287 | 2118 9769 3707 14055 | 3068 2806 | 2941 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * 21 0 * | * * 0 * | * 17 0 * | * * | * | | 5- 9 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 10-14 | * * 0 * | 11 19 0 * | * 15 0 * | * 12 | 10 | | 15-19 | 22 190 * * | 38 113 * * | 30 151 * 132 | 44 48 | 46 | | 20-24 | 130 1593 291 283 | 116 622 123 631 | 123 1098 205 463 | 322 184 | 250 | | 25-29 | 318 3836 547 731 | 191 1507 229 675 | 253 2648 384 700 | 774 362 | 560 | | 30-34 | 498 6141 881 1279 | 278 2710 650 375 | 386 4390 764 817 | 1231 599 | 902 | | 35-39 | 632 10996 1492 2017 | 348 4577 977 1274 | 487 7709 1228 1631 | 1981 911 | 1423 | | 40-44 | 907 18841 2023 3325 | 470 7372 1472 1991 | 682 12966 1740 2622 | 3226 1386 | 2266 | | 45-49 | 1277 27530 2458 6420 | 704 11319 2074 2443 | 983 19191 2245 4358 | 4659 2103 | 3325 | | 50-54 | 1865 34753 3815 6368 | 1109 16012 3211 4141 | 1476 25133 3487 5186 | 6108 3085 | 4531 | | 55-59 | 2648 38846 5626 6374 | 1546 21709 3791 5453 | 2083 30058 4659 5879 | 7342 4199 | 5707 | | 60-64 | 3939 41979 7005 10431 | 2260 28452 4954 6476 | 3083 35061 5919 8402 | 8902 5695 | 7242 | | 65-69 | 6157 41503 10393 12616 | 3352 34877 8011 9200 | 4725 38098 9164 10846 | 10819 7545 | 9140 | | 70-74 | 8862 46044 16022 16068 | 4522 43131 10336 13075 | 6644 44538 13049 14498 | 13865 9668 | 11724 | | 75-79 | 11381 43503 21226 12211 | 5433 40637 15983 14405 | 8329 41983 18488 13194 | 15761 10321 | 12988 | | 80-84 | 12412 43497 25144 11123 | 5293 36382 18796 14637 | 8759 39837 21682 12822 | 16748 9764 | 13180 | | 85 plus | 8444 25598 16981 10920 | 2905 20675 9855 8724 | 5596 22988 13290 9859 | 10903 5424 | 8105 | | All Age | 1678 11299 2129 2369 | 1064 7932 1766 1913 | 1366 9530 1942 2139 | 2875 1986 | 2421 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1792 15522 3408 3714 | 918 9644 2438 2765 | 1290 12471 2853 3222 | 3238 1799 | 2429 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31, 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 20 * * 0 | 24 * * * | 22 12 * * | 19 22 | 21 | | 5- 9 | 80 91 * 240 | 72 75 92 * | 76 83 63 174 | 81 73 | 77 | | 10-14 | 170 280 179 * | 165 213 310 * | 167 245 245 172 | 184 176 | 180 | | 15-19 | 345 1105 484 724 | 360 751 449 1343 | 352 923 466 1042 | 448 421 | 434 | | 20-24 | 789 2888 1286 1471 | 693 1999 1292 1400 | 740 2436 1289 1434 | 1078 886 | 979 | | 25-29 | 1359 4529 2225 2246 | 1046 2767 1340 1969 | 1199 3631 1770 2092 | 1798 1282 | 1531 | | 30-34 | 1831 5015 2937 2691 | 1180 3310 1802 2576 | 1500 4145 2354 2636 | 2281 1484 | 1872 | | 35-39 | 2199 6528 3630 4717 | 1282 3693 3238 3408 | 1730 5075 3423 4038 | 2817 1673 | 2229 | | 40-44 | 2575 8819 4989 5433 | 1468 4432 3677 2863 | 2008 6567 4300 4107 | 3471 1930 | 2678 | | 45-49 | 2852 10045 5314 5888 | 1617 5042 4073 4227 | 2216 7448 4655 5019 | 3861 2153 | 2981 | | 50-54 | 3128 9078 6086 7753 | 1725 4904 4106 5982 | 2407 6926 5063 6845 | 4017 2244 | 3106 | | 55-59 | 3361 8601 6646 9199 | 1796 5160 4331 4665 | 2558 6831 5441 6875 | 4184 2333 | 3235 | | 60-64 | 3592 8042 5580 6646 | 1890 5264 3525 4614 | 2724 6619 4511 5585 | 4252 2398 | 3303 | | 65-69 | 3723 6699 6347 8177 | 1969 4890 4341 4796 | 2828 5771 5306 6448 | 4231 2448 | 3320 | | 70-74 | 3911 6886 9014 5912 | 1949 5230 4513 4479 | 2908 6036 6693 5168 | 4485 2477 | 3459 | | 75-79 | 3742 5228 7933 10775 | 1777 4325 6194 4522 | 2733 4758 6971 7510 | 4129 2278 | 3185 | | 80-84 | 3471 4421 7196 6520 | 1391 2907 5202 3473 | 2404 3645 6104 5024 | 3742 1735 | 2718 | | 85 plus | 1978 2045 4688 * | 630 2090 1702 * | 1283 2060 3094 * | 2065 849 | 1446 | | All Age | 1811 4118 2796 2860 | 1092 2662 2157 2168 | 1446 3353 2467 2512 | 2137 1343 | 1731 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1820 4815 3323 3737 | 1050 2899 2338 2557 | 1409 3832 2793 3103 | 2223 1308 | 1735 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 19 * 0 * | 17 * * * | 18 * * * | 16 17 | 17 | | 5- 9 | 32 39 * * | 25 16 * * | 28 27 * * | 33 23 | 28 | | 10-14 | 40 17 * * | 36 42 68 0 | 38 29 38 * | 37 38 | 37 | | 15-19 | 46 26 * * | 54 46 112 0 | 50 36 77 * | 44 55 | 49 | | 20-24 | 71 40 69 * | 81 45 * 0 | 76 42 57 * | 67 75 | 71 | | 25-29 | 87 56 73 * | 82 36 * * | 84 46 52 * | 82 75 | 79 | | 30-34 | 105 126 * * | 112 128 66 268 | 109 127 42 241 | 106 114 | 110 | | 35-39 | 245 220 118 312 | 181 240 69 304 | 212 230 92 308 | 237 185 | 211 | | 40-44 | 563 492 400 790 | 330 549 310 435 | 444 519 356 608 | 550 357 | 452 | | 45-49 | 1087 1122 770 1185 | 786 977 475 698 | 932 1045 613 940 | 1077 798 | 935 | | 50-54 | 1613 1768 1164 2270 | 1282 1791 657 1482 | 1442 1777 909 1859 | 1619 1324 | 1469 | | 55-59 | 1780 1969 1468 796 | 1588 1625 996 2496 | 1681 1792 1221 1659 | 1782 1578 | 1677 | | 60-64 | 1641 1956 1284 2030 | 1620 1943 952 1619 | 1631 1949 1110 1817 | 1671 1637 | 1654 | | 65-69 | 1343 1633 1340 * | 1404 1283 1126 1468 | 1375 1454 1232 1265 | 1378 1379 | 1378 | | 70-74 | 1082 1267 1497 * | 1019 1265 897 * | 1049 1264 1198 * | 1116 1041 | 1078 | | 75-79 | 642 1137 1442 * | 603 872 879 * | 620 1002 1138 1406 | 738 651 | 693 | | 80-84 | 548 763 * 0 | 310 333 * 0 | 427 543 497 0 | 567 319 | 440 | | 85 plus | 280 619 * 0 | 74 356 * 0 | 175 483 * 0 | 318 113 | 213 | | All Age | 507 412 324 415 | 456 438 263 387 | 482 426 293 401 | 489 447 | 467 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 506 560 427 550 | 429 513 310 496 | 465 533 364 523 | 507 433 | 468 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 30 53 * 0 | * 0 0 0 | 17 26 * 0 | 32 * | 17 | | 5- 9 | 44 62 * 0 | * * 0 0 | 26 33 * 0 | 46 * | 26 | | 10-14 | 81 100 86 * | 33 * * * | 57 56 49 115 | 84 30 | 57 | | 15-19 | 126 174 101 0 | 76 32 * 0 | 100 101 57 0 | 130 67 | 98 | | 20-24 | 162 171 120 * | 110 56 * * | 136 112 75 199 | 162 101 | 131 | | 25-29 | 224 222 86 391 | 122 91 80 281 | 172 155 84 336 | 220 118 | 168 | | 30-34 | 176 232 172 266 | 125 55 55 322 | 151 141 111 294 | 184 116 | 149 | | 35-39 | 164 210 93 284 | 146 98 115 277 | 154 153 104 278 | 168 139 | 153 | | 40-44 | 189 238 112 * | 125 161 111 * | 156 198 110 * | 192 128 | 159 | | 45-49 | 168 293 207 * | 152 179 143 * | 158 232 173 * | 182 154 | 168 | | 50-54 | 186 323 154 * | 172 286 323 * | 178 303 239 265 | 203 191 | 197 | | 55-59 | 240 506 417 * | 205 297 387 0 | 222 398 397 * | 283 221 | 251 | | 60-64 | 341 763 562 1015 | 228 420 301 * | 284 588 422 580 | 408 255 | 329 | | 65-69 | 430 1237 657 * | 249 489 436 * | 338 854 538 705 | 543 289 | 413 | | 70-74 | 729 1533 764 * | 263 611 752 * | 491 1062 763 700 | 834 326 | 574 | | 75-79 | 944 1597 1648 2394 | 292 487 611 * | 609 1033 1139 1599 | 1063 333 | 689 | | 80-84 | 1124 2777 2254 * | 185 393 901 0 | 641 1559 1554 * | 1373 235 | 789 | | 85 plus | 723 1890 * * | 72 229 * 0 | 388 1037 * * | 893 96 | 485 | | All Age | 220 295 183 270 | 129 134 131 145 | 174 210 156 207 | 228 130 | 178 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 228 410 264 416 | 123 156 163 169 | 169 266 206 269 | 246 126 | 178 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 126 140 * * | 50 68 * * | 87 104 29 * | 124 52 | 87 | | 5- 9 | 218 279 * * | 92 122 106 * | 154 199 84 143 | 219 97 | 157 | | 10-14 | 350 464 312 232 | 206 186 117 * | 276 322 213 190 | 362 199 | 279 | | 15-19 | 516 591 491 796 | 377 566 449 746 | 445 577 468 772 | 526 406 | 465 | | 20-24 | 723 967 551 1187 | 637 1350 792 714 | 680 1165 674 949 | 752 734 | 744 | | 25-29 | 942 1795 706 1175 | 838 2284 819 1069 | 889 2046 763 1120 | 1043 1022 | 1033 | | 30-34 | 1055 2428 601 1385 | 1014 3140 1018 1690 | 1035 2792 813 1543 | 1216 1289 | 1254 | | 35-39 | 1020 3107 640 2216 | 1042 3691 1305 1357 | 1030 3399 979 1767 | 1278 1386 | 1335 | | 40-44 | 1045 3809 948 1580 | 1050 3642 1416 1929 | 1046 3700 1186 1744 | 1389 1394 | 1391 | | 45-49 | 1025 3892 839 1922 | 1155 3506 1780 2133 | 1087 3654 1315 1996 | 1377 1474 | 1426 | | 50-54 | 1147 3727 808 2492 | 1296 3646 2230 1994 | 1220 3678 1520 2232 | 1467 1629 | 1550 | | 55-59 | 1323 3959 1421 4128 | 1420 3373 1605 2168 | 1370 3650 1514 3112 | 1681 1674 | 1676 | | 60-64 | 1599 4153 1645 2861 | 1566 3949 1937 2833 | 1584 4047 1786 2840 | 1934 1891 | 1912 | | 65-69 | 1983 3942 2124 4088 | 1747 3683 2180 4306 | 1864 3810 2143 4190 | 2253 2030 | 2139 | | 70-74 | 2286 5211 2261 3031 | 1665 3634 2499 4237 | 1969 4404 2388 3627 | 2659 1966 | 2304 | | 75-79 | 2599 4793 3297 4549 | 1497 3027 2714 3350 | 2029 3882 3002 3904 | 2907 1747 | 2313 | | 80-84 | 2672 4930 2427 * | 1137 2776 2150 2480 | 1880 3828 2246 2973 | 2943 1387 | 2147 | | 85 plus | 1741 3470 2661 4963 | 517 1682 * * | 1110 2548 1690 2623 | 2008 672 | 1325 | | All Age | 976 1994 701 1334 | 894 2135 1041 1222 | 934 2068 876 1277 | 1093 1063 | 1078 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 990 2414 866 1716 | 859 2300 1125 1484 | 914 2338 991 1583 | 1143 1034 | 1078 | (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.13 (Continued) December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1993-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 16 16 0 0 | * * 0 0 | 11 * 0 0 | 15 * | 10 | | 5- 9 | 34 27 * 0 | 30 * * * | 32 17 * * | 32 26 | 29 | | 10-14 | 63 97 * * | 55 56 * * | 59 76 * * | 65 54 | 60 | | 15-19 | 116 225 86 289 | 95 143 149 * | 105 182 120 219 | 130 103 | 116 | | 20-24 | 245 488 164 567 | 209 371 233 439 | 226 428 200 501 | 276 232 | 253 | | 25-29 | 380 948 411 418 | 270 496 275 450 | 324 718 342 432 | 454 300 | 375 | | 30-34 | 437 1035 661 1199 | 372 598 450 885 | 404 812 554 1038 | 527 408 | 465 | | 35-39 | 502 1659 889 795 | 362 744 310 443 | 430 1191 591 613 | 664 409 | 532 | | 40-44 | 570 2037 716 1218 | 402 1050 745 653 | 484 1532 730 925 | 766 498 | 628 | | 45-49 | 557 2866 960 1390 | 412 1300 927 698 | 482 2059 947 1030 | 869 543 | 700 | | 50-54 | 656 2561 1331 1882 | 488 1600 1099 1380 | 570 2067 1200 1622 | 930 658 | 789 | | 55-59 | 742 3077 1499 1521 | 554 2182 954 2168 | 645 2622 1218 1851 | 1070 787 | 924 | | 60-64 | 928 3413 1987 2307 | 643 2891 1540 2104 | 782 3146 1752 2207 | 1291 971 | 1127 | | 65-69 | 1068 3847 2301 4789 | 803 3122 1744 2544 | 933 3479 2012 3650 | 1496 1145 | 1316 | | 70-74 | 1405 3917 2070 2728 | 776 3322 2596 3753 | 1084 3611 2342 3240 | 1757 1188 | 1467 | | 75-79 | 1664 3617 3503 5028 | 823 2980 2829 1675 | 1233 3290 3097 3337 | 2001 1173 | 1579 | | 80-84 | 1703 3495 3468 * | 818 2621 3398 2977 | 1249 3047 3423 3047 | 2002 1156 | 1570 | | 85 plus | 1239 2169 1900 * | 446 2077 1254 * | 830 2119 1545 * | 1382 683 | 1026 | | All Age | 486 1213 638 822 | 360 880 566 658 | 421 1038 601 739 | 583 437 | 508 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 498 1557 836 1177 | 338 1021 687 859 | 409 1279 756 1005 | 622 417 | 509 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 10 * * 0 | * 16 0 0 | 10 15 * 0 | 11 * | 10 | | 5- 9 | 16 24 * 0 | 10 * 0 0 | 13 15 * 0 | 16 * | 13 | | 10-14 | 22 51 0 * | 24 29 0 0 | 23 40 0 * | 25 24 | 24 | | 15-19 | 44 94 0 * | 35 93 * 0 | 39 93 * * | 48 42 | 45 | | 20-24 | 74 190 * 0 | 55 103 * 0 | 64 146 38 0 | 87 60 | 73 | | 25-29 | 118 244 * * | 98 194 * * | 108 218 * 152 | 131 108 | 119 | | 30-34 | 151 332 77 * | 164 213 55 * | 158 272 66 187 | 172 166 | 169 | | 35-39 | 242 549 87 * | 213 269 74 * | 227 406 80 153 | 274 215 | 244 | | 40-44 | 328 701 224 395 | 228 440 86 * | 277 569 153 210 | 372 248 | 308 | | 45-49 | 359 1128 95 408 | 242 492 * * | 299 804 74 267 | 447 266 | 354 | | 50-54 | 362 1416 * * | 264 658 140 0 | 312 1032 114 * | 484 307 | 393 | | 55-59 | 404 1608 * 1014 | 276 1261 166 788 | 339 1441 140 911 | 552 403 | 475 | | 60-64 | 356 2261 220 * | 306 1691 238 809 | 330 1971 224 685 | 592 482 | 535 | | 65-69 | 427 2296 379 0 | 346 2309 254 1664 | 385 2315 317 857 | 659 602 | 630 | | 70-74 | 340 1958 414 * | 251 1619 242 * | 295 1792 333 * | 552 425 | 487 | | 75-79 | 322 1444 * 0 | 232 1533 * * | 280 1510 320 * | 469 408 | 438 | | 80-84 | 299 1273 0 0 | 169 1096 832 * | 237 1189 453 * | 416 319 | 366 | | 85 plus | 218 805 * 0 | 98 433 * 0 | 161 623 * 0 | 299 153 | 224 | | All Age | 196 528 80 151 | 157 422 74 162 | 176 472 77 157 | 232 188 | 210 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 197 700 101 194 | 151 498 97 228 | 172 595 101 217 | 244 182 | 211 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.1 * * * | 1.3 * * * | 0.8 * * * | 1.0 1.2 | 0.8 | | 5- 9 | * 0.0 0.0 0.0 | * * * 0.0 | * * * 0.0 | * * | 0.4 | | 10-14 | * 0.0 0.0 0.0 | * * 0.0 0.0 | * * 0.0 0.0 | * * | * | | 15-19 | 1.3 5.7 * 0.0 | 1.6 6.4 * 0.0 | 1.0 4.3 * 0.0 | 1.3 1.6 | 1.0 | | 20-24 | 4.7 19.4 * * | 5.5 25.6 * 86.8 | 3.6 16.2 * 51.0 | 4.6 5.7 | 3.7 | | 25-29 | 12.9 44.1 30.7 82.6 | 13.8 48.5 29.7 159.1 | 9.4 32.9 21.4 90.9 | 12.1 13.0 | 8.9 | | 30-34 | 21.1 62.2 57.1 208.1 | 19.5 56.6 53.9 245.9 | 14.3 41.9 39.3 161.9 | 19.4 17.9 | 13.1 | | 35-39 | 25.5 76.2 83.6 324.0 | 21.6 67.4 71.1 319.5 | 16.7 50.6 54.6 227.3 | 23.6 20.2 | 15.5 | | 40-44 | 30.1 115.8 113.0 530.9 | 24.6 92.0 78.5 432.3 | 19.3 73.4 68.1 339.3 | 29.5 23.9 | 18.8 | | 45-49 | 35.5 186.1 167.8 904.2 | 28.5 153.6 129.7 751.1 | 22.6 119.8 104.9 581.6 | 38.8 31.4 | 24.8 | | 50-54 | 44.6 286.6 286.2 1330.2 | 36.3 252.9 200.1 1200.3 | 28.5 190.1 172.7 891.8 | 53.8 45.5 | 35.1 | | 55-59 | 54.8 392.9 390.1 1836.8 | 48.1 350.1 325.4 1779.0 | 36.3 261.8 251.2 1273.0 | 70.3 62.4 | 46.8 | | 60-64 | 63.6 463.9 543.8 2249.9 | 58.5 435.9 411.9 2365.8 | 43.2 317.7 337.4 1632.1 | 83.4 77.5 | 56.8 | | 65-69 | 68.4 468.6 681.8 2527.1 | 62.4 489.4 551.6 2801.2 | 46.2 338.6 435.2 1886.2 | 88.1 86.3 | 61.7 | | 70-74 | 72.0 543.7 793.8 2283.9 | 62.6 549.9 711.9 2958.2 | 47.5 386.3 529.8 1871.7 | 97.2 93.8 | 67.5 | | 75-79 | 74.5 566.2 969.3 2511.3 | 57.1 530.7 868.6 2792.8 | 46.5 385.9 642.0 1870.7 | 102.4 90.6 | 68.2 | | 80-84 | 78.2 622.4 1117.0 2601.3 | 50.8 501.2 1012.2 2542.1 | 45.9 397.2 741.2 1819.0 | 111.2 86.8 | 70.0 | | 85 plus | 64.0 463.8 1037.2 * | 29.6 288.7 770.7 1327.3 | 34.5 268.3 626.4 843.2 | 87.0 52.4 | 50.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 7.4 46.1 60.8 213.5 | 6.3 42.9 50.8 224.9 | 4.8 31.4 39.3 157.4 | 8.0 7.0 | 5.2 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.0 5.8 0.0 * | * * 0.0 * | 0.7 3.8 0.0 * | 1.1 1.0 | 0.7 | | 5- 9 | 1.3 * 0.0 0.0 | 1.5 * 0.0 0.0 | 1.0 * 0.0 0.0 | 1.1 1.3 | 0.8 | | 10-14 | 1.5 * 0.0 * | 1.9 5.8 0.0 * | 1.2 3.7 0.0 * | 1.4 1.8 | 1.1 | | 15-19 | 2.7 18.2 * * | 3.7 14.2 * * | 2.3 11.5 * 39.9 | 3.2 3.6 | 2.4 | | 20-24 | 6.6 55.3 42.9 85.6 | 6.4 34.1 28.3 131.7 | 4.6 32.2 25.5 79.5 | 9.0 7.0 | 5.6 | | 25-29 | 10.0 87.6 57.9 138.2 | 7.9 52.5 36.2 137.8 | 6.3 50.6 33.8 97.2 | 14.0 9.5 | 8.3 | | 30-34 | 11.7 107.7 72.4 184.6 | 8.8 67.3 60.1 100.4 | 7.3 62.9 46.9 103.8 | 17.0 11.4 | 10.1 | | 35-39 | 13.0 145.1 96.3 239.4 | 9.7 88.0 74.9 187.9 | 8.0 83.9 60.7 150.8 | 21.6 14.0 | 12.6 | | 40-44 | 16.3 205.8 119.2 330.9 | 11.7 119.8 95.6 248.9 | 9.9 117.8 76.1 204.2 | 29.7 18.4 | 17.1 | | 45-49 | 20.7 284.0 145.8 512.3 | 15.3 166.9 125.0 307.8 | 12.8 163.0 95.3 294.2 | 40.3 25.1 | 23.2 | | 50-54 | 28.5 375.0 212.9 593.8 | 21.6 229.6 186.0 460.2 | 17.7 217.4 140.5 370.7 | 53.5 34.9 | 31.4 | | 55-59 | 37.7 441.2 294.8 679.5 | 27.9 291.6 229.0 598.6 | 23.3 262.0 184.9 449.9 | 64.9 44.5 | 38.7 | | 60-64 | 48.6 496.5 374.9 981.3 | 35.1 354.9 280.4 724.1 | 29.8 303.0 231.4 605.6 | 76.1 54.7 | 46.3 | | 65-69 | 62.0 514.5 512.6 1214.0 | 42.0 407.1 381.5 949.0 | 37.2 326.3 317.5 765.0 | 85.4 64.1 | 52.9 | | 70-74 | 80.4 638.8 714.4 1560.7 | 50.6 508.6 500.7 1258.2 | 47.0 406.2 431.6 995.5 | 108.5 79.4 | 66.6 | | 75-79 | 106.9 745.7 1045.7 1709.9 | 61.5 565.3 781.7 1553.3 | 60.9 464.8 648.4 1142.3 | 135.2 93.0 | 81.2 | | 80-84 | 145.4 1003.4 1476.5 2065.4 | 71.5 658.4 1141.8 1905.6 | 79.8 594.6 922.1 1393.7 | 183.3 111.1 | 105.6 | | 85 plus | 150.9 890.6 1466.9 2328.2 | 55.1 513.3 939.6 1454.0 | 78.8 506.7 865.9 1385.1 | 177.2 86.8 | 96.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 6.7 60.3 59.1 121.7 | 4.2 41.3 44.0 96.4 | 3.7 35.6 35.6 76.5 | 8.4 5.5 | 4.8 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.5 * * 0.0 | 2.8 * * * | 1.9 3.2 * * | 2.2 2.4 | 1.6 | | 5- 9 | 5.0 12.2 * 72.4 | 4.9 11.2 25.5 * | 3.5 8.3 14.9 43.6 | 4.5 4.4 | 3.1 | | 10-14 | 7.4 21.8 34.5 * | 7.5 19.3 46.2 * | 5.2 14.5 28.9 43.1 | 6.8 6.9 | 4.8 | | 15-19 | 10.7 43.9 59.1 132.2 | 11.3 36.7 57.9 182.8 | 7.8 28.5 41.4 113.9 | 10.7 10.8 | 7.6 | | 20-24 | 16.3 74.5 90.2 194.8 | 15.7 61.2 91.6 196.1 | 11.3 48.1 64.3 138.2 | 16.8 15.6 | 11.4 | | 25-29 | 20.8 95.2 116.9 242.2 | 18.5 71.2 87.6 235.4 | 13.9 59.1 72.5 167.9 | 21.5 18.1 | 14.0 | | 30-34 | 22.5 97.3 132.3 267.8 | 18.2 74.3 100.1 262.9 | 14.4 60.9 82.3 187.9 | 23.0 18.3 | 14.6 | | 35-39 | 24.3 111.8 150.2 366.1 | 18.6 79.0 136.4 307.2 | 15.2 67.9 101.1 237.6 | 25.3 19.2 | 15.8 | | 40-44 | 27.5 140.8 187.2 422.9 | 20.8 92.9 151.1 298.5 | 17.1 83.6 119.4 256.3 | 29.9 21.6 | 18.3 | | 45-49 | 30.9 171.5 214.4 490.7 | 23.1 111.4 175.2 404.9 | 19.2 101.1 137.6 315.9 | 34.6 24.8 | 21.1 | | 50-54 | 36.9 191.6 268.9 655.2 | 26.9 127.1 210.3 553.1 | 22.7 113.7 169.9 427.4 | 40.5 28.8 | 24.6 | | 55-59 | 42.5 207.6 320.5 816.3 | 30.1 142.1 244.8 553.6 | 25.8 124.6 200.1 489.0 | 45.8 32.3 | 27.8 | | 60-64 | 46.4 217.3 334.6 783.3 | 32.1 152.6 236.5 611.2 | 28.0 131.7 202.9 492.4 | 49.2 34.3 | 29.7 | | 65-69 | 48.2 206.7 400.6 977.3 | 32.2 152.4 280.8 685.1 | 28.8 127.5 242.4 592.5 | 50.6 34.9 | 30.4 | | 70-74 | 53.4 247.0 535.8 946.6 | 33.2 177.1 330.9 736.4 | 31.1 150.8 311.2 595.7 | 58.0 37.9 | 34.3 | | 75-79 | 61.3 258.5 639.3 1606.2 | 35.1 184.4 486.6 870.3 | 34.9 157.4 396.4 895.4 | 65.9 41.8 | 38.6 | | 80-84 | 76.9 319.9 789.9 1581.4 | 36.6 186.1 600.6 928.2 | 41.9 182.9 488.8 920.6 | 81.6 44.7 | 45.9 | | 85 plus | 73.0 251.7 770.8 * | 25.7 163.2 390.5 * | 37.8 148.2 419.4 * | 73.7 32.8 | 39.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 6.5 30.8 49.7 111.3 | 4.7 21.5 37.6 83.9 | 3.9 18.5 30.4 68.0 | 6.7 4.8 | 4.0 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.4 * 0.0 * | 2.4 * * * | 1.7 * * * | 2.0 2.1 | 1.4 | | 5- 9 | 3.2 8.0 * * | 2.9 5.3 * * | 2.1 4.7 * * | 2.9 2.5 | 1.9 | | 10-14 | 3.6 5.4 * * | 3.5 8.6 21.7 0.0 | 2.5 5.1 11.7 * | 3.1 3.2 | 2.2 | | 15-19 | 3.9 6.7 * * | 4.4 9.1 28.9 0.0 | 2.9 5.7 16.8 * | 3.4 3.9 | 2.6 | | 20-24 | 4.8 8.8 21.0 * | 5.4 9.1 * 0.0 | 3.6 6.3 13.4 * | 4.2 4.6 | 3.1 | | 25-29 | 5.2 10.5 21.2 * | 5.2 8.2 * * | 3.7 6.6 12.4 * | 4.6 4.5 | 3.2 | | 30-34 | 5.4 15.4 * * | 5.6 14.6 19.2 84.8 | 3.9 10.6 11.0 57.0 | 4.9 5.1 | 3.5 | | 35-39 | 8.1 20.5 27.1 94.2 | 7.0 20.1 19.9 91.8 | 5.3 14.3 16.6 65.7 | 7.3 6.4 | 4.8 | | 40-44 | 12.8 33.2 53.0 161.3 | 9.8 32.7 43.9 116.4 | 8.0 23.2 34.5 98.8 | 11.7 9.3 | 7.4 | | 45-49 | 19.1 57.3 81.6 220.2 | 16.1 49.0 59.8 164.5 | 12.4 37.6 49.9 137.3 | 17.7 15.0 | 11.5 | | 50-54 | 26.5 84.6 117.6 354.6 | 23.2 76.8 84.1 275.3 | 17.5 56.9 72.2 222.5 | 24.9 21.9 | 16.5 | | 55-59 | 30.9 99.3 150.6 240.2 | 28.3 79.8 117.4 405.0 | 20.9 63.3 94.7 237.2 | 29.1 26.1 | 19.5 | | 60-64 | 31.4 107.1 160.5 432.9 | 29.7 92.7 122.9 362.0 | 21.6 70.6 100.2 280.7 | 30.1 27.8 | 20.4 | | 65-69 | 29.0 102.0 184.1 * | 27.2 78.0 143.0 379.0 | 19.8 63.9 116.2 258.9 | 28.2 25.3 | 18.9 | | 70-74 | 28.1 105.9 218.3 * | 24.0 87.1 147.5 * | 18.4 68.2 131.7 * | 28.1 23.4 | 18.2 | | 75-79 | 25.4 120.6 272.6 * | 20.5 82.8 183.3 * | 16.2 72.6 161.0 381.6 | 28.2 21.3 | 17.5 | | 80-84 | 30.5 132.9 * 0.0 | 17.3 63.0 * 0.0 | 17.4 72.4 134.1 0.0 | 31.1 17.7 | 17.7 | | 85 plus | 27.5 138.5 * 0.0 | 8.8 67.4 * 0.0 | 14.1 75.7 * 0.0 | 29.3 12.3 | 15.5 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.4 11.2 18.4 42.3 | 3.0 9.3 14.1 38.1 | 2.2 7.1 11.4 28.3 | 3.2 2.8 | 2.1 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 3.0 9.3 * 0.0 | 1.2 0.0 0.0 0.0 | 1.6 4.6 * 0.0 | 2.8 1.0 | 1.4 | | 5- 9 | 3.7 10.0 * 0.0 | 1.6 * 0.0 0.0 | 2.0 5.1 * 0.0 | 3.4 1.4 | 1.8 | | 10-14 | 5.1 13.1 23.9 * | 3.4 * * * | 3.0 6.9 12.8 34.9 | 4.6 2.9 | 2.7 | | 15-19 | 6.4 17.4 27.0 0.0 | 5.2 7.6 * 0.0 | 4.1 9.3 14.3 0.0 | 5.8 4.4 | 3.6 | | 20-24 | 7.4 18.1 27.6 * | 6.2 10.2 * * | 4.8 10.3 15.4 51.5 | 6.6 5.4 | 4.2 | | 25-29 | 8.4 21.0 22.9 101.1 | 6.3 12.9 21.4 88.9 | 5.2 12.2 15.9 67.4 | 7.5 5.6 | 4.6 | | 30-34 | 7.0 20.9 32.0 84.2 | 5.9 9.6 17.5 92.9 | 4.6 11.3 17.9 62.8 | 6.5 5.2 | 4.1 | | 35-39 | 6.6 20.0 24.0 89.8 | 6.3 12.8 25.7 87.6 | 4.5 11.8 17.6 62.3 | 6.1 5.5 | 4.1 | | 40-44 | 7.4 23.1 28.1 * | 6.0 17.7 26.3 * | 4.7 14.4 19.0 * | 6.9 5.5 | 4.4 | | 45-49 | 7.5 29.3 42.4 * | 7.1 21.0 32.8 * | 5.1 17.7 26.6 * | 7.3 6.5 | 4.9 | | 50-54 | 9.0 36.1 42.8 * | 8.5 30.7 59.0 * | 6.1 23.5 36.5 84.0 | 8.9 8.3 | 6.1 | | 55-59 | 11.3 50.3 80.3 * | 10.2 34.1 73.2 0.0 | 7.6 30.0 53.7 * | 11.8 9.8 | 7.6 | | 60-64 | 14.3 66.9 106.2 306.1 | 11.1 43.1 69.2 * | 9.0 39.4 61.8 161.0 | 15.3 11.0 | 9.3 | | 65-69 | 16.4 88.8 128.9 * | 11.4 48.2 88.9 * | 9.9 49.9 77.0 196.0 | 18.4 11.9 | 10.8 | | 70-74 | 23.0 116.5 156.0 * | 12.2 60.5 135.0 * | 12.8 64.8 103.8 222.2 | 25.0 13.7 | 14.0 | | 75-79 | 30.8 142.9 291.4 757.1 | 14.2 61.9 152.9 * | 16.6 76.9 165.6 418.0 | 33.6 15.6 | 18.2 | | 80-84 | 43.7 253.5 442.1 * | 13.3 68.4 250.0 0.0 | 22.3 128.8 250.4 * | 51.2 16.7 | 26.2 | | 85 plus | 44.1 242.0 * * | 8.7 54.0 * 0.0 | 21.9 121.2 * * | 50.1 11.0 | 24.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.3 10.2 15.8 42.4 | 1.6 5.1 10.7 21.8 | 1.3 5.2 9.0 21.0 | 2.2 1.5 | 1.3 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 6.3 15.1 * * | 4.1 10.7 * * | 3.7 9.2 9.4 * | 5.6 3.7 | 3.3 | | 5- 9 | 8.3 21.3 * * | 5.6 14.3 27.4 * | 5.0 12.7 17.2 39.9 | 7.5 5.1 | 4.5 | | 10-14 | 10.6 28.1 45.5 70.2 | 8.4 18.1 28.4 * | 6.7 16.5 26.6 44.8 | 9.6 7.4 | 6.0 | | 15-19 | 13.1 32.1 59.5 138.6 | 11.6 31.8 57.9 136.3 | 8.7 22.5 41.4 97.4 | 11.8 10.7 | 7.9 | | 20-24 | 15.6 43.1 59.1 175.0 | 15.1 50.3 71.7 140.0 | 10.8 33.3 46.7 111.9 | 14.3 14.3 | 10.1 | | 25-29 | 17.3 59.9 65.9 175.2 | 16.5 64.7 68.5 173.4 | 11.9 44.2 47.6 123.2 | 16.4 16.2 | 11.5 | | 30-34 | 17.1 67.7 59.8 192.1 | 16.9 72.4 75.2 213.0 | 12.0 49.6 48.2 144.0 | 16.8 17.0 | 11.9 | | 35-39 | 16.5 77.1 63.0 250.9 | 16.8 79.0 86.6 193.9 | 11.8 55.1 53.9 156.9 | 17.1 17.5 | 12.2 | | 40-44 | 17.5 92.5 81.6 228.1 | 17.6 84.2 93.8 245.0 | 12.4 62.1 62.3 166.4 | 18.9 18.4 | 13.2 | | 45-49 | 18.5 106.8 85.2 280.3 | 19.5 92.9 115.8 287.6 | 13.4 70.0 72.3 197.9 | 20.7 20.5 | 14.5 | | 50-54 | 22.3 122.8 98.0 371.4 | 23.3 109.5 155.0 319.3 | 16.1 81.9 91.9 243.8 | 24.5 24.5 | 17.3 | | 55-59 | 26.6 140.8 148.2 546.8 | 26.8 114.9 149.0 377.4 | 18.8 90.3 105.2 328.3 | 29.2 27.2 | 19.9 | | 60-64 | 31.0 156.1 181.7 513.9 | 29.2 132.2 175.3 478.9 | 21.3 101.9 125.7 350.0 | 33.3 30.4 | 22.5 | | 65-69 | 35.2 158.6 231.7 691.1 | 30.3 132.3 199.0 649.2 | 23.2 102.9 151.7 472.5 | 36.8 31.5 | 24.1 | | 70-74 | 40.8 214.9 268.4 677.9 | 30.7 147.6 246.2 716.2 | 25.4 129.3 182.4 491.0 | 44.8 33.3 | 27.7 | | 75-79 | 51.1 247.5 412.1 1043.7 | 32.3 154.3 322.2 749.0 | 29.8 144.1 261.2 632.7 | 55.2 35.6 | 32.5 | | 80-84 | 67.4 337.8 458.7 * | 33.1 181.9 386.1 784.5 | 36.9 189.5 294.7 697.9 | 72.7 38.8 | 40.5 | | 85 plus | 68.5 327.9 580.7 1569.7 | 23.2 146.4 * * | 35.4 176.5 312.1 778.3 | 74.2 28.5 | 38.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.8 22.5 26.4 76.4 | 4.3 19.0 26.0 65.2 | 3.2 14.4 18.3 49.1 | 4.8 4.3 | 3.2 | ------------------------------------------------------------------------------------------------------------------------- (Continued) Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.14 (Continued) Standard Errors For Adjusted December 31 Point Prevalence Rates Per Ten Million Population Of Reported ESRD Therapy By Primary Disease Causing ESRD By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1993-1996 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 2.2 5.1 0.0 0.0 | 1.4 * 0.0 0.0 | 1.3 2.6 0.0 0.0 | 1.9 1.2 | 1.1 | | 5- 9 | 3.3 6.7 * 0.0 | 3.1 * * * | 2.3 3.7 * * | 2.9 2.7 | 1.9 | | 10-14 | 4.5 12.9 * * | 4.3 9.9 * * | 3.1 8.1 * * | 4.1 3.8 | 2.8 | | 15-19 | 6.2 19.8 25.0 83.6 | 5.8 16.0 33.4 * | 4.2 12.6 21.3 51.8 | 5.8 5.4 | 3.9 | | 20-24 | 9.1 30.6 32.3 121.0 | 8.6 26.3 38.9 109.8 | 6.2 20.1 25.4 81.5 | 8.6 8.0 | 5.9 | | 25-29 | 11.0 43.5 50.3 104.5 | 9.4 30.1 39.6 112.5 | 7.2 26.3 31.9 76.6 | 10.8 8.8 | 6.9 | | 30-34 | 11.0 44.2 62.7 178.7 | 10.2 31.6 50.0 154.1 | 7.5 27.0 40.0 117.6 | 11.0 9.6 | 7.3 | | 35-39 | 11.6 56.3 74.3 150.3 | 9.9 35.5 42.2 110.8 | 7.6 33.0 42.1 92.4 | 12.3 9.5 | 7.7 | | 40-44 | 12.9 67.6 70.9 200.2 | 10.8 45.2 68.0 142.6 | 8.4 40.3 49.1 121.5 | 14.0 11.0 | 8.8 | | 45-49 | 13.7 91.6 91.1 238.4 | 11.7 56.5 83.6 164.5 | 8.9 53.3 62.2 143.0 | 16.6 12.4 | 10.3 | | 50-54 | 16.9 101.8 125.7 322.9 | 14.3 72.6 108.8 265.7 | 11.0 62.0 82.3 207.9 | 19.7 15.6 | 12.5 | | 55-59 | 19.9 124.2 152.2 331.9 | 16.7 92.4 114.9 377.4 | 12.9 77.0 94.8 252.1 | 23.6 18.8 | 15.0 | | 60-64 | 23.6 141.5 199.7 461.5 | 18.7 113.1 156.3 412.8 | 15.0 90.2 125.8 309.5 | 27.7 22.1 | 17.6 | | 65-69 | 25.8 156.6 241.2 747.9 | 20.5 121.8 177.9 499.1 | 16.4 98.7 148.8 446.9 | 31.1 24.2 | 19.5 | | 70-74 | 32.0 186.3 256.8 643.1 | 20.9 141.1 250.9 674.1 | 18.9 116.1 180.1 464.7 | 37.0 27.1 | 22.7 | | 75-79 | 40.9 215.0 424.8 1097.2 | 23.9 153.1 328.9 529.6 | 23.4 131.0 262.6 606.2 | 46.9 30.4 | 27.6 | | 80-84 | 53.8 284.4 548.3 * | 28.1 176.7 485.5 859.4 | 29.9 165.8 365.6 697.7 | 61.3 37.4 | 35.4 | | 85 plus | 57.8 259.2 490.8 * | 21.6 162.7 335.2 * | 30.2 151.5 293.6 * | 61.2 29.8 | 33.5 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.4 18.5 26.5 66.6 | 2.6 13.1 21.8 51.4 | 2.1 11.1 16.9 40.9 | 3.6 2.7 | 2.2 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.8 * * 0.0 | 1.7 5.3 0.0 0.0 | 1.2 3.5 * 0.0 | 1.6 1.6 | 1.1 | | 5- 9 | 2.2 6.3 * 0.0 | 1.9 * 0.0 0.0 | 1.4 3.5 * 0.0 | 2.0 1.6 | 1.3 | | 10-14 | 2.7 9.3 0.0 * | 2.9 7.2 0.0 0.0 | 1.9 5.8 0.0 * | 2.5 2.5 | 1.8 | | 15-19 | 3.8 12.8 0.0 * | 3.5 12.9 * 0.0 | 2.6 9.0 * * | 3.5 3.4 | 2.4 | | 20-24 | 4.9 19.1 * 0.0 | 4.4 13.9 * 0.0 | 3.3 11.7 11.0 0.0 | 4.8 4.1 | 3.1 | | 25-29 | 6.1 22.1 * * | 5.6 18.8 * * | 4.1 14.4 * 45.9 | 5.8 5.3 | 3.9 | | 30-34 | 6.4 25.0 21.4 * | 6.8 18.9 17.5 * | 4.7 15.6 13.7 50.0 | 6.3 6.1 | 4.4 | | 35-39 | 8.0 32.4 23.2 * | 7.6 21.3 20.7 * | 5.5 19.2 15.4 46.3 | 7.9 6.9 | 5.2 | | 40-44 | 9.8 39.7 39.7 114.0 | 8.2 29.3 23.2 * | 6.3 24.6 22.7 58.4 | 9.7 7.7 | 6.2 | | 45-49 | 11.0 57.5 28.7 129.3 | 8.9 34.8 * * | 7.0 33.4 17.0 74.2 | 11.7 8.7 | 7.2 | | 50-54 | 12.5 75.7 * * | 10.5 46.5 38.8 0.0 | 8.1 44.1 25.1 * | 14.2 10.6 | 8.8 | | 55-59 | 14.7 89.8 * 271.0 | 11.8 70.3 47.9 227.6 | 9.4 57.1 32.3 178.7 | 16.9 13.5 | 10.7 | | 60-64 | 14.6 115.2 66.5 * | 12.9 86.5 61.4 256.0 | 9.7 71.7 44.0 171.6 | 19.1 15.6 | 12.2 | | 65-69 | 16.3 121.0 97.9 0.0 | 13.5 104.7 67.9 403.5 | 10.5 80.2 59.6 208.0 | 20.7 17.8 | 13.6 | | 70-74 | 15.7 131.7 114.8 * | 11.9 98.5 76.7 * | 9.8 82.1 69.8 * | 21.8 16.2 | 13.4 | | 75-79 | 18.0 135.8 * 0.0 | 12.7 109.8 * * | 11.1 88.2 86.6 * | 23.6 18.3 | 14.8 | | 80-84 | 22.6 171.6 0.0 0.0 | 12.7 114.3 240.2 * | 13.1 102.8 131.2 * | 29.0 20.6 | 17.6 | | 85 plus | 24.2 158.0 * 0.0 | 10.1 74.3 * 0.0 | 13.3 87.2 * 0.0 | 29.8 14.7 | 16.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.1 12.6 9.0 24.5 | 1.8 9.2 8.7 27.3 | 1.3 7.6 6.5 19.0 | 2.2 1.8 | 1.4 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Prevalent cases for December 31 of 1993, 1994, 1995, and 1996 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.15 December 31 Point Prevalence Counts of Reported ESRD Therapy By State After Dropping Territories and Unknown States Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 1,740 2,010 3,213 3,477 3,799 4,169 4,492 4,897 5,349 5,861 Alaska 108 128 150 165 195 229 248 416 673 560 Arizona 1,711 1,876 2,142 2,394 2,684 3,036 3,301 3,645 4,069 4,351 Arkansas 1,095 1,226 1,310 1,451 1,627 1,760 1,943 2,212 2,487 2,655 California 13,909 15,071 16,859 18,693 20,657 22,316 23,763 26,190 28,379 30,190 Colorado 1,192 1,249 1,439 1,597 1,760 1,984 2,152 2,370 2,513 2,695 Connecticut 1,696 1,775 1,947 2,137 2,363 2,563 2,717 2,915 3,161 3,382 Delaware 380 436 466 526 585 673 720 765 849 920 District of Columbia 799 811 916 1,005 1,111 1,218 1,336 1,353 1,425 1,524 Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 Georgia 3,728 4,159 4,699 5,225 5,895 6,607 7,232 8,079 8,922 9,653 Hawaii 667 745 827 889 978 1,054 1,182 1,332 1,428 1,489 Idaho 335 363 414 481 519 549 606 673 722 780 Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 Indiana 2,610 2,901 3,194 3,510 3,814 4,235 4,611 4,872 5,367 5,786 Iowa 1,224 1,311 1,456 1,612 1,737 1,942 2,075 2,232 2,324 2,462 Kansas 1,004 1,089 1,230 1,402 1,538 1,666 1,750 1,919 2,058 2,174 Kentucky 1,600 1,771 1,937 2,125 2,383 2,670 2,889 2,952 3,321 3,525 Louisiana 2,638 2,954 3,274 3,610 3,981 4,387 4,752 5,183 5,700 6,112 Maine 355 478 518 574 608 667 729 812 906 963 Maryland 2,516 2,812 3,165 3,613 4,065 4,489 4,886 5,266 5,857 6,560 Massachusetts 2,741 3,005 3,258 3,527 3,852 4,241 4,608 4,933 5,314 5,584 Michigan 4,463 4,909 5,567 6,184 6,756 7,535 8,246 9,082 9,878 10,779 Minnesota 1,943 2,094 2,296 2,559 2,781 3,012 3,222 3,507 3,803 4,064 Mississippi 1,638 1,837 2,041 2,239 2,469 2,729 3,008 3,376 3,671 3,966 Missouri 2,533 2,784 3,156 3,502 3,841 4,169 4,559 4,923 5,391 5,788 Montana 308 321 382 425 468 504 541 587 661 684 Nebraska 627 684 779 862 939 1,078 1,144 1,262 1,390 1,437 Nevada 473 517 578 631 725 809 882 1,012 1,133 1,260 New Hampshire 369 409 479 522 569 598 629 683 734 757 New Jersey 4,485 4,756 5,185 5,751 6,377 6,948 7,379 8,078 8,673 9,214 New Mexico 676 802 890 998 1,136 1,250 1,335 1,468 1,668 1,822 New York 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 North Carolina 3,636 4,002 4,470 5,050 5,608 6,309 7,005 7,797 8,528 9,221 North Dakota 248 263 328 368 406 458 500 542 550 560 Ohio 5,269 5,870 6,544 7,198 7,812 8,541 9,183 9,858 10,906 11,782 Oklahoma 1,207 1,392 1,580 1,773 1,930 2,148 2,373 2,626 2,909 3,091 Oregon 1,126 1,252 1,413 1,562 1,756 1,862 2,003 2,196 2,337 2,498 Pennsylvania 6,672 7,262 7,982 8,829 9,595 10,370 10,956 11,919 13,073 13,795 Rhode Island 472 521 592 634 693 736 795 875 926 980 South Carolina 2,220 2,475 2,782 3,112 3,413 3,755 4,071 4,540 5,012 5,407 South Dakota 320 351 372 404 435 455 507 555 638 697 Tennessee 2,493 2,721 3,163 3,456 3,847 4,252 4,530 5,089 5,586 5,985 Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 Utah 591 680 740 776 857 913 1,044 1,140 1,251 1,291 Vermont 196 220 236 249 288 304 318 344 398 424 Virginia 3,289 3,678 4,033 4,418 4,956 5,500 5,991 6,353 7,005 7,722 Washington 1,887 2,074 2,330 2,566 2,811 2,997 3,258 3,609 3,922 4,194 West Virginia 822 918 1,000 1,070 1,180 1,267 1,375 1,466 1,591 1,707 Wisconsin 2,184 2,482 2,799 3,032 3,377 3,755 4,024 4,405 4,759 5,073 Wyoming 129 162 180 189 205 204 224 245 274 294 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 123,737 135,740 151,935 168,060 185,591 203,918 220,480 240,898 262,853 281,896 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.16 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By State Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 459.13 528.80 833.81 887.77 954.10 1028.87 1090.81 1173.54 1265.11 1367.31 Alaska 231.48 259.14 309.35 322.94 367.69 415.85 439.23 716.11 1138.82 919.18 Arizona 526.01 560.66 624.48 680.23 744.81 814.19 851.29 888.70 941.64 969.13 Arkansas 478.50 535.16 568.19 623.44 691.65 735.64 800.58 898.55 997.53 1052.61 California 512.31 541.40 592.14 644.84 698.85 740.66 777.85 845.60 901.88 942.42 Colorado 396.93 412.01 466.31 501.28 537.80 582.35 609.03 648.77 668.89 698.14 Connecticut 564.58 579.11 629.90 683.16 750.11 806.70 848.78 904.77 973.41 1032.36 Delaware 659.16 729.26 767.46 843.30 918.29 1031.24 1069.25 1111.49 1196.38 1262.45 District of Columbia 1349.46 1380.90 1570.43 1755.74 1945.87 2151.66 2380.63 2454.92 2622.58 2835.06 Florida 574.09 621.15 673.41 736.23 797.93 863.64 912.45 959.85 1026.83 1092.58 Georgia 639.24 700.95 776.56 839.76 921.22 1000.61 1062.25 1151.93 1237.27 1299.98 Hawaii 699.77 759.00 815.11 852.72 897.94 944.17 1038.60 1153.85 1220.68 1255.50 Idaho 353.33 377.01 421.00 474.26 493.36 505.71 544.43 586.78 612.98 649.56 Illinois 577.69 610.62 655.04 718.77 788.05 853.27 920.88 994.51 1070.65 1128.04 Indiana 501.75 549.90 600.08 649.45 693.34 758.25 815.92 852.00 926.84 986.98 Iowa 471.78 500.60 549.86 600.29 637.05 706.21 745.38 794.81 820.65 862.00 Kansas 431.33 463.75 517.47 581.45 630.33 673.75 700.19 759.38 805.74 843.81 Kentucky 459.78 503.92 548.75 595.42 657.02 724.79 772.90 778.22 863.55 904.51 Louisiana 672.74 753.03 831.18 906.99 982.26 1062.59 1134.59 1220.46 1324.78 1402.85 Maine 314.29 411.08 442.53 486.36 511.31 556.30 602.88 665.70 735.05 773.07 Maryland 602.66 656.20 721.64 806.77 888.55 960.22 1021.26 1077.11 1173.52 1289.32 Massachusetts 490.25 534.09 574.59 619.25 670.10 731.52 784.81 830.12 882.76 914.96 Michigan 513.14 557.67 626.71 685.61 741.92 817.90 885.04 965.36 1038.50 1120.18 Minnesota 485.18 515.57 555.97 609.28 650.67 690.62 724.85 775.16 826.75 868.50 Mississippi 682.21 757.18 834.25 906.57 979.11 1067.03 1155.14 1275.79 1365.99 1454.84 Missouri 520.51 565.50 635.83 698.17 756.03 812.24 877.04 936.09 1013.46 1076.16 Montana 406.67 417.80 488.97 541.86 579.76 614.29 646.43 685.85 759.20 773.86 Nebraska 420.41 457.53 514.93 563.04 605.09 684.81 719.60 781.75 849.65 866.43 Nevada 504.38 513.86 540.57 554.99 588.77 623.45 642.26 691.80 730.48 769.23 New Hampshire 364.51 395.36 458.47 493.31 530.76 550.15 570.92 607.41 639.25 647.23 New Jersey 618.28 649.49 702.76 772.93 845.92 911.36 955.56 1032.90 1096.03 1150.72 New Mexico 498.24 580.01 629.25 686.92 754.96 804.59 836.25 894.94 991.82 1056.12 New York 598.10 627.11 676.98 726.66 791.31 857.23 915.90 981.88 1042.48 1091.58 North Carolina 592.30 639.91 701.59 777.16 846.65 934.47 1014.50 1104.23 1181.09 1248.93 North Dakota 405.33 426.94 547.20 609.22 674.31 740.64 809.34 866.07 861.98 868.82 Ohio 518.49 570.57 632.13 686.71 735.68 793.22 843.99 897.89 984.38 1052.70 Oklahoma 404.36 464.68 524.04 581.36 624.23 682.20 743.52 812.47 889.18 932.73 Oregon 426.74 466.91 513.37 555.41 607.05 628.78 658.99 707.87 738.72 773.09 Pennsylvania 586.37 634.38 694.72 760.80 819.52 878.23 922.11 998.37 1089.48 1144.43 Rhode Island 493.14 544.11 612.63 651.63 713.80 759.70 817.06 895.93 943.46 990.41 South Carolina 707.55 775.02 855.00 935.73 1005.00 1083.92 1154.54 1267.00 1375.02 1455.60 South Dakota 477.35 520.05 548.41 587.80 631.26 652.10 714.51 774.47 881.23 949.78 Tennessee 545.70 589.12 678.12 726.51 793.18 860.64 898.18 989.07 1064.06 1117.41 Texas 546.11 601.05 660.75 725.69 787.45 854.53 909.17 977.43 1031.97 1092.96 Utah 367.94 418.94 448.40 457.05 491.54 509.86 563.94 597.89 636.26 638.61 Vermont 387.71 422.66 456.52 464.09 527.13 545.73 563.72 602.09 684.88 717.92 Virginia 591.35 649.64 698.19 750.23 821.25 888.13 945.29 981.68 1062.62 1151.58 Washington 433.39 460.71 503.47 539.76 572.46 593.04 628.17 677.61 719.32 752.21 West Virginia 471.72 525.26 575.23 612.61 667.00 708.27 765.10 811.09 876.85 934.83 Wisconsin 489.53 547.07 607.89 647.76 709.11 774.20 815.58 878.27 933.65 979.60 Wyoming 286.94 370.05 420.79 431.90 461.30 454.04 488.55 524.46 575.36 609.32 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.17 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By State Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 State Alabama 11.18 11.95 14.86 15.18 15.56 15.98 16.28 16.75 17.26 17.81 Alaska 23.25 23.88 26.23 25.96 26.90 27.87 28.13 35.25 43.73 38.69 Arizona 12.90 13.10 13.62 14.01 14.45 14.82 14.84 14.72 14.74 14.67 Arkansas 14.68 15.48 15.86 16.50 17.24 17.58 18.18 19.09 19.97 20.39 California 4.44 4.49 4.62 4.76 4.89 4.98 5.05 5.23 5.35 5.42 Colorado 11.78 11.89 12.50 12.72 12.94 13.15 13.17 13.34 13.34 13.44 Connecticut 14.06 14.02 14.49 14.94 15.53 15.99 16.31 16.76 17.29 17.72 Delaware 34.43 35.45 35.98 37.14 38.22 39.89 39.89 40.15 40.97 41.50 District of Columbia 49.02 49.53 52.77 56.15 58.81 61.86 65.19 66.65 69.27 72.35 Florida 7.17 7.34 7.52 7.75 7.93 8.13 8.24 8.33 8.50 8.66 Georgia 10.69 11.05 11.48 11.73 12.07 12.34 12.50 12.80 13.07 13.19 Hawaii 28.27 28.91 29.38 29.54 29.18 29.33 30.31 31.63 32.27 32.48 Idaho 19.66 20.20 21.05 21.88 21.79 21.67 22.17 22.63 22.80 23.24 Illinois 7.40 7.54 7.76 8.07 8.37 8.65 8.92 9.22 9.52 9.73 Indiana 9.96 10.31 10.71 11.03 11.27 11.68 12.03 12.20 12.63 12.95 Iowa 13.77 14.05 14.59 15.10 15.38 16.08 16.39 16.83 17.01 17.35 Kansas 13.87 14.26 14.92 15.66 16.17 16.57 16.77 17.34 17.74 18.07 Kentucky 11.66 12.10 12.58 13.01 13.53 14.06 14.39 14.32 14.97 15.21 Louisiana 13.30 14.02 14.66 15.20 15.64 16.08 16.47 16.94 17.51 17.90 Maine 17.02 19.11 19.68 20.53 20.91 21.63 22.38 23.38 24.41 24.89 Maryland 12.23 12.55 12.98 13.54 14.02 14.37 14.62 14.83 15.30 15.88 Massachusetts 9.60 9.93 10.22 10.54 10.88 11.28 11.58 11.82 12.10 12.23 Michigan 7.81 8.07 8.49 8.79 9.08 9.45 9.76 10.13 10.43 10.77 Minnesota 11.27 11.49 11.79 12.19 12.44 12.64 12.80 13.10 13.40 13.61 Mississippi 17.19 17.94 18.71 19.36 19.83 20.50 21.09 21.94 22.49 23.04 Missouri 10.47 10.82 11.41 11.87 12.24 12.60 12.99 13.33 13.78 14.12 Montana 23.70 23.78 25.46 26.78 27.14 27.57 27.90 28.34 29.50 29.55 Nebraska 17.16 17.79 18.71 19.39 19.90 20.95 21.33 22.02 22.77 22.82 Nevada 23.81 23.08 22.92 22.49 22.08 22.04 21.69 21.76 21.69 21.65 New Hampshire 19.35 19.87 21.22 21.80 22.41 22.59 22.82 23.26 23.59 23.50 New Jersey 9.44 9.59 9.90 10.32 10.67 10.98 11.14 11.49 11.75 11.97 New Mexico 19.47 20.75 21.32 21.92 22.51 22.82 22.90 23.34 24.24 24.68 New York 6.07 6.16 6.35 6.53 6.77 7.01 7.20 7.41 7.60 7.74 North Carolina 9.96 10.22 10.58 11.00 11.35 11.79 12.12 12.49 12.76 12.97 North Dakota 26.46 26.79 30.61 32.16 34.20 34.75 36.50 37.42 36.72 36.65 Ohio 7.26 7.54 7.90 8.16 8.37 8.61 8.82 9.04 9.41 9.68 Oklahoma 11.79 12.58 13.29 13.90 14.27 14.75 15.27 15.85 16.47 16.75 Oregon 13.03 13.46 13.87 14.23 14.61 14.64 14.76 15.12 15.27 15.45 Pennsylvania 7.33 7.57 7.88 8.18 8.42 8.66 8.82 9.14 9.52 9.73 Rhode Island 23.33 24.37 25.64 26.26 27.37 28.17 29.06 30.30 30.97 31.59 South Carolina 15.25 15.77 16.37 16.90 17.28 17.73 18.10 18.78 19.37 19.72 South Dakota 27.20 28.24 28.82 29.65 30.56 30.74 31.79 32.88 34.83 35.88 Tennessee 11.12 11.45 12.19 12.46 12.86 13.24 13.36 13.86 14.21 14.41 Texas 6.08 6.31 6.52 6.73 6.89 7.05 7.15 7.30 7.40 7.51 Utah 15.39 16.28 16.66 16.55 16.90 16.94 17.49 17.71 17.98 17.76 Vermont 28.37 29.02 30.27 29.82 31.41 31.51 31.77 32.51 34.30 34.80 Virginia 10.50 10.87 11.12 11.38 11.73 12.01 12.22 12.31 12.67 13.07 Washington 10.22 10.31 10.59 10.78 10.88 10.88 11.03 11.29 11.48 11.60 West Virginia 16.80 17.61 18.43 18.95 19.57 19.98 20.68 21.19 21.97 22.60 Wisconsin 10.69 11.15 11.63 11.87 12.28 12.68 12.88 13.23 13.52 13.73 Wyoming 25.95 29.80 32.20 31.96 32.60 32.03 32.80 33.58 34.76 35.49 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Rates per million based on the December 31, 1995 U.S. resident population by state for five-year age groups, sex, and White/non- White race groups. Table B.18 December 31 Point Prevalence Counts of Reported ESRD Therapy By Network Before Dropping Territories and Unknown Networks Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 5,829 6,408 7,030 7,643 8,373 9,109 9,796 10,562 11,439 12,090 (NY) Net. of N.Y. 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 (NJ) Trans-Atlantic R. C. 5,999 6,401 7,056 7,828 8,626 9,445 10,040 11,004 11,775 12,561 (PA) ESRD Net. Org. #4 7,052 7,698 8,448 9,355 10,180 11,043 11,676 12,684 13,922 14,715 (VA) Mid Atlantic R. C. 7,426 8,219 9,114 10,106 11,312 12,474 13,588 14,438 15,878 17,513 (NC) Southeastern Kidney Council 9,584 10,636 11,951 13,387 14,916 16,671 18,308 20,416 22,462 24,281 (FL) ESRD Net. of Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 (MS) Network 8 5,871 6,568 8,417 9,172 10,115 11,150 12,030 13,362 14,606 15,812 (IN) Tri-state R. N. 9,479 10,542 11,675 12,833 14,009 15,446 16,683 17,682 19,594 21,093 (IL) Renal Net. of Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 (MN) Renal Net. of upper midwest 9,158 10,099 11,362 12,547 13,755 15,215 16,499 18,091 19,628 21,173 (MO) ESRD net. #12 5,388 5,868 6,621 7,378 8,055 8,855 9,528 10,336 11,163 11,861 (OK) ESRD net. #13 4,940 5,572 6,164 6,834 7,538 8,295 9,068 10,021 11,096 11,858 (TX) Net. of Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 (CO) Inter-mountain ESRD net. 4,772 5,286 5,969 6,585 7,367 8,196 8,938 9,880 10,908 11,713 (WA) Northwest Renal Net. 3,764 4,138 4,689 5,199 5,749 6,141 6,656 7,481 8,315 8,716 (N-CA) Trans-pacific ESRD Net. 5,954 6,573 7,363 8,193 9,092 9,844 10,694 11,807 12,617 13,477 (S-CA) Southern California Net. 8,669 9,301 10,397 11,483 12,654 13,664 14,400 15,880 17,391 18,438 Unknown Network 85 153 313 380 515 729 1,111 2,497 2,890 2,036 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 125,383 137,596 154,193 170,611 188,466 207,282 224,401 246,486 269,046 287,515 Table B.19 December 31 Point Prevalence Counts of Reported ESRD Therapy By Network After Dropping Territories and Unknown Networks Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 5,829 6,408 7,030 7,643 8,373 9,109 9,796 10,562 11,439 12,090 (NY) Net. of N.Y. 10,071 10,661 11,604 12,575 13,790 15,062 16,231 17,543 18,780 19,847 (NJ) Trans-Atlantic R. C. 4,485 4,756 5,185 5,751 6,377 6,948 7,379 8,078 8,673 9,214 (PA) ESRD Net. Org. #4 7,052 7,698 8,448 9,355 10,180 11,043 11,676 12,684 13,922 14,715 (VA) Mid Atlantic R. C. 7,426 8,219 9,114 10,106 11,312 12,474 13,588 14,438 15,878 17,513 (NC) Southeastern Kidney Council 9,584 10,636 11,951 13,387 14,916 16,671 18,308 20,416 22,462 24,281 (FL) ESRD Net. of Florida 6,627 7,362 8,204 9,211 10,241 11,357 12,288 13,274 14,551 15,851 (MS) Network 8 5,871 6,568 8,417 9,172 10,115 11,150 12,030 13,362 14,606 15,812 (IN) Tri-state R. N. 9,479 10,542 11,675 12,833 14,009 15,446 16,683 17,682 19,594 21,093 (IL) Renal Net. of Illinois 6,279 6,705 7,263 8,051 8,935 9,785 10,677 11,623 12,610 13,395 (MN) Renal Net. of upper midwest 9,158 10,099 11,362 12,547 13,755 15,215 16,499 18,091 19,628 21,173 (MO) ESRD net. #12 5,388 5,868 6,621 7,378 8,055 8,855 9,528 10,336 11,163 11,861 (OK) ESRD net. #13 4,940 5,572 6,164 6,834 7,538 8,295 9,068 10,021 11,096 11,858 (TX) Net. of Texas 8,436 9,406 10,553 11,851 13,244 14,801 16,190 17,905 19,421 21,085 (CO) Inter-mountain ESRD net. 4,772 5,286 5,969 6,585 7,367 8,196 8,938 9,880 10,908 11,713 (WA) Northwest Renal Net. 3,764 4,138 4,689 5,199 5,749 6,141 6,656 7,481 8,315 8,716 (N-CA) Trans-pacific ESRD Net. 5,907 6,515 7,289 8,099 8,981 9,706 10,545 11,642 12,416 13,241 (S-CA) Southern California Net. 8,669 9,301 10,397 11,483 12,654 13,664 14,400 15,880 17,391 18,438 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 123,737 135,740 151,935 168,060 185,591 203,918 220,480 240,898 262,853 281,896 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.20 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Network Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 478.09 518.11 563.74 607.90 660.07 712.43 757.99 808.79 865.93 903.97 (NY) Net. of N.Y. 598.10 627.11 676.98 726.66 791.31 857.23 915.90 981.88 1042.48 1091.58 (NJ) Trans-Atlantic R. C. 618.28 649.49 702.76 772.93 845.92 911.36 955.56 1032.90 1096.03 1150.72 (PA) ESRD Net. Org. #4 590.12 639.20 698.75 765.55 825.15 886.86 930.59 1004.76 1095.60 1151.16 (VA) Mid Atlantic R. C. 611.06 664.47 725.48 791.95 869.81 940.93 1005.92 1051.18 1138.48 1237.05 (NC) Southeastern Kidney Council 633.81 690.95 762.20 834.22 908.35 991.01 1062.06 1156.32 1242.69 1310.84 (FL) ESRD Net. of Florida 574.09 621.15 673.41 736.23 797.93 863.64 912.45 959.85 1026.83 1092.58 (MS) Network 8 544.81 604.37 766.33 821.95 889.83 964.30 1021.58 1116.20 1200.28 1278.39 (IN) Tri-state R. N. 502.30 552.00 607.29 659.17 708.86 770.54 822.94 862.89 945.85 1006.75 (IL) Renal Net. of Illinois 577.69 610.62 655.04 718.77 788.05 853.27 920.88 994.51 1070.65 1128.04 (MN) Renal Net. of upper midwest 495.97 540.33 600.86 653.26 706.99 770.53 823.79 891.22 954.04 1015.06 (MO) ESRD net. #12 477.63 515.13 575.35 633.27 682.60 742.42 789.45 846.70 904.51 951.20 (OK) ESRD net. #13 536.84 604.87 665.89 730.91 793.52 857.58 924.58 1008.24 1102.28 1163.34 (TX) Net. of Texas 546.11 601.05 660.75 725.69 787.45 854.53 909.17 977.43 1031.97 1092.96 (CO) Inter-mountain ESRD net. 454.74 492.05 542.16 579.51 628.07 673.56 707.01 748.61 794.03 823.87 (WA) Northwest Renal Net. 411.04 440.90 487.34 526.99 564.57 587.15 620.00 679.94 739.19 757.87 (N-CA) Trans-pacific ESRD Net. 562.92 605.47 660.76 718.91 749.71 793.68 848.21 921.48 965.26 1009.65 (S-CA) Southern California Net. 492.72 516.16 563.84 612.13 677.82 718.63 747.95 814.63 879.52 917.04 Table B.21 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Network Adjusted By Age, Race and Sex Year 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 Network (CT) Net. of New England 6.40 6.59 6.82 7.02 7.26 7.49 7.67 7.87 8.09 8.21 (NY) Net. of N.Y. 6.07 6.16 6.35 6.53 6.77 7.01 7.20 7.41 7.60 7.74 (NJ) Trans-Atlantic R. C. 9.44 9.59 9.90 10.32 10.67 10.98 11.14 11.49 11.75 11.97 (PA) ESRD Net. Org. #4 7.17 7.40 7.70 8.00 8.23 8.47 8.62 8.92 9.27 9.47 (VA) Mid Atlantic R. C. 7.20 7.42 7.67 7.93 8.21 8.44 8.63 8.74 9.02 9.33 (NC) Southeastern Kidney Council 6.58 6.78 7.04 7.26 7.47 7.69 7.85 8.08 8.27 8.39 (FL) ESRD Net. of Florida 7.17 7.34 7.52 7.75 7.93 8.13 8.24 8.33 8.50 8.66 (MS) Network 8 7.23 7.56 8.44 8.66 8.90 9.16 9.32 9.65 9.91 10.14 (IN) Tri-state R. N. 5.23 5.44 5.67 5.86 6.02 6.21 6.38 6.49 6.75 6.92 (IL) Renal Net. of Illinois 7.40 7.54 7.76 8.07 8.37 8.65 8.92 9.22 9.52 9.73 (MN) Renal Net. of upper midwest 5.27 5.45 5.70 5.88 6.06 6.27 6.42 6.62 6.80 6.97 (MO) ESRD net. #12 6.61 6.81 7.14 7.43 7.64 7.91 8.10 8.33 8.55 8.72 (OK) ESRD net. #13 7.74 8.19 8.55 8.90 9.18 9.43 9.71 10.06 10.45 10.66 (TX) Net. of Texas 6.08 6.31 6.52 6.73 6.89 7.05 7.15 7.30 7.40 7.51 (CO) Inter-mountain ESRD net. 6.70 6.87 7.10 7.21 7.36 7.47 7.49 7.53 7.60 7.60 (WA) Northwest Renal Net. 6.86 6.98 7.22 7.40 7.50 7.53 7.62 7.87 8.10 8.11 (N-CA) Trans-pacific ESRD Net. 7.53 7.68 7.89 8.12 7.96 8.09 8.27 8.54 8.65 8.76 (S-CA) Southern California Net. 5.37 5.42 5.58 5.75 6.06 6.17 6.24 6.46 6.66 6.74 Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.22 December 31 Point Prevalence Counts Of Reported ESRD Therapy By Age, By Sex, By Race 1991-1993 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 5347 1472 186 103 7108| 3775 938 192 81 4986| 9122 2410 378 184 12094| | 20-44 | 66926 31993 3050 1097 103066| 48686 20997 2600 855 73138|115612 52990 5650 1952 176204| | 45-64 | 74291 41867 3525 2026 121709| 58112 38113 3185 2005 101415|132403 79980 6710 4031 223124| | 65-74 | 43760 15588 1676 597 61621| 39071 23708 1917 1040 65736| 82831 39296 3593 1637 127357| | 75 plus | 26545 6537 946 245 34273| 22345 11157 976 349 34827| 48890 17694 1922 594 69100| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 216869 97457 9383 4068 327777|171989 94913 8870 4330 280102|388858 192370 18253 8398 607879| ----------------------------------------------------------------------------------------------------------------------- 1994-1996 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 6196 1963 233 121 8513| 4294 1184 228 111 5817| 10490 3147 461 232 14330| | 20-44 | 76042 39418 3845 1457 120762| 54948 27778 3444 1191 87361|130990 67196 7289 2648 208123| | 45-64 | 98750 57575 5402 2957 164684| 74915 50705 4774 2840 133234|173665 108280 10176 5797 297918| | 65-74 | 55362 20481 2605 935 79383| 49154 30774 2913 1492 84333|104516 51255 5518 2427 163716| | 75 plus | 37787 9117 1674 341 48919| 31467 15559 1801 578 49405| 69254 24676 3475 919 98324| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 274137 128554 13759 5811 422261|214778 126000 13160 6212 360150|488915 254554 26919 12023 782411| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31, 1995. Includes Medicare patients only. Table B.23 December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy Specific Rates By Sex, By Race, By Age And Rates Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 59 85 44 80 | 44 55 48 65 | 52 72 48 76 | 63 47 | 55 | | 20-44 | 527 1734 551 836 | 391 1025 445 655 | 453 1433 505 776 | 693 474 | 580 | | 45-64 | 1203 6357 1759 4374 | 894 4656 1385 3993 | 1076 5743 1683 4576 | 1967 1478 | 1714 | | 65-74 | 1990 8006 3543 5616 | 1419 8605 3102 7894 | 1703 8308 3334 6716 | 2842 2442 | 2640 | | 75 plus | 1955 6023 3804 4256 | 911 5387 3118 3761 | 1320 5247 3195 3647 | 2362 1464 | 1904 | | All Age | 689 2148 756 1262 | 526 1885 679 1322 | 606 2010 717 1292 | 872 711 | 790 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 710 2918 1057 1893 | 493 2261 859 1864 | 591 2582 948 1883 | 952 682 | 804 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 66 109 50 91 | 48 67 51 85 | 58 89 53 89 | 72 52 | 62 | | 20-44 | 603 2082 640 1073 | 446 1328 537 891 | 507 1716 590 1011 | 786 552 | 666 | | 45-64 | 1480 7873 2224 5776 | 1075 5577 1712 5108 | 1337 7162 2147 6024 | 2478 1818 | 2138 | | 65-74 | 2486 10065 4795 8123 | 1795 10830 3927 10671 | 2139 10506 4403 9324 | 3590 3097 | 3341 | | 75 plus | 2542 7807 5567 5027 | 1214 7097 4456 5316 | 1748 6921 4640 4751 | 3107 1979 | 2532 | | All Age | 849 2711 989 1718 | 643 2401 890 1810 | 744 2548 938 1764 | 1089 890 | 987 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 864 3612 1379 2505 | 596 2841 1102 2499 | 716 3218 1226 2513 | 1166 838 | 987 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table B.24 Standard Errors For Adjusted December 31 Point Prevalence Rates Per Million Population Of Reported ESRD Therapy By Sex, By Race, By Age Adjusted For Age, Race, And Sex 1991-1993 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 2.2 3.2 7.9 | 0.7 1.8 3.4 7.2 | 0.5 1.4 2.5 5.6 | 0.7 0.6 | 0.5 | | 20-44 | 2.0 9.6 9.9 25.2 | 1.7 7.0 8.7 22.4 | 1.3 6.2 6.7 17.6 | 2.1 1.7 | 1.3 | | 45-64 | 4.4 31.0 29.6 97.1 | 3.7 23.8 24.5 89.1 | 2.9 20.7 21.2 74.2 | 5.8 4.7 | 3.7 | | 65-74 | 9.5 64.1 86.5 229.8 | 7.1 55.8 70.8 244.8 | 5.9 42.8 56.6 168.3 | 12.0 9.8 | 7.7 | | 75 plus | 11.9 74.5 123.6 271.9 | 6.0 51.0 99.8 201.3 | 6.5 43.4 78.9 160.4 | 14.4 8.6 | 8.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 9.6 11.8 31.6 | 1.1 7.3 9.6 29.1 | 0.9 5.9 7.5 21.4 | 1.6 1.2 | 1.0 | ------------------------------------------------------------------------------------------------------------------------- 1994-1996 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 2.4 3.2 8.2 | 0.7 1.9 3.4 8.1 | 0.5 1.6 2.4 5.9 | 0.7 0.6 | 0.5 | | 20-44 | 2.1 10.4 10.3 28.1 | 1.9 7.9 9.1 25.8 | 1.4 6.6 6.9 19.7 | 2.2 1.8 | 1.4 | | 45-64 | 4.7 32.8 30.2 106.2 | 3.9 24.7 24.7 95.8 | 3.2 22.4 22.2 82.1 | 6.3 5.1 | 4.0 | | 65-74 | 10.5 70.3 93.9 265.6 | 8.0 61.7 72.7 276.2 | 6.6 47.3 60.3 190.9 | 13.2 10.9 | 8.5 | | 75 plus | 13.0 81.7 136.0 272.2 | 6.8 56.8 105.0 221.1 | 7.2 48.2 84.4 165.3 | 15.8 9.6 | 9.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.6 10.4 12.6 34.6 | 1.2 8.0 10.0 32.5 | 1.0 6.4 7.9 23.7 | 1.8 1.4 | 1.1 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Patients alive on ESRD therapy and not lost to followup on December 31 of each year. Includes Medicare patients only. Cases where race is Other or Unknown are excluded from this table. See tables B.6 and B.7 and notes at beginning of this Section. The population base is the U.S. resident population on December 31 of each year. Standard population for adjustment is the July 1, 1995 U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Reference Tables: Prevalence Of Reported ESRD Therapy USRDS 1998 Annual Data Report USRDS Patient Database Updated From HCFA REBUS September 1997. Quality Control Filters Applied. See section introduction and Chapter XIII discussion of the database and of the methodologies used.